Literature DB >> 26890690

How age and gender predict illness course in a first-episode nonaffective psychosis cohort.

Richard J Drake1, Jean Addington, Ananth C Viswanathan, Shôn W Lewis, Jack Cotter, Alison R Yung, Kathryn M Abel.   

Abstract

OBJECTIVE: Male gender and young age at onset of schizophrenia are traditionally associated with poor treatment outcome and often used to determine prognosis. However, many studies use nonincident samples and fail to adjust for symptom severity at onset. We hypothesized that age and gender would influence severity of presentation but would not predict outcome after adjustment for symptoms at presentation.
METHOD: 628 people with first-episode ICD-9 and DSM-IV nonaffective psychosis from 2 historical cohorts recruited from sequential presentations in Canada and the United Kingdom (1996-1998) were assessed prospectively at presentation and over 12-18 months using the Positive and Negative Syndrome Scale (PANSS).
RESULTS: Models of the age-at-onset distributions with 2 underlying modes at similar ages in women (ages 23 years and 47 years) and men (ages 22 years and 46 years) had relatively good fits compared to single-mode models (χ(2)1 better by 9.2 for females, 8.0 for males, both P < .05). At presentation, scores for negative symptoms were 1.84 points worse for males (95% CI, 1.05 to 2.58; P < .001) in a mixed effects model. Younger age also predicted higher negative scores at presentation (partial correlation r = -0.18, P < .01; P < .001 in the mixed effects model). Findings were similar for cognitive-disorganized symptoms. However, after controlling for baseline symptoms, age at onset and gender did not significantly predict subsequent symptom course in the mixed effects models.
CONCLUSIONS: Gender and age at onset are independently associated with symptoms at presentation but not with medium-term course of schizophrenia. This finding reinforces the importance of early identification and prevention of severe negative symptoms at first episode, whatever an individual's age and gender. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 26890690     DOI: 10.4088/JCP.14m09369

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

1.  Structural anomalies of the peripheral olfactory system in psychosis high-risk subjects.

Authors:  Bruce I Turetsky; Paul J Moberg; Megan Quarmley; Erich Dress; Monica E Calkins; Kosha Ruparel; Karthik Prabhakaran; Raquel E Gur; David R Roalf
Journal:  Schizophr Res       Date:  2017-09-30       Impact factor: 4.939

2.  Is an Early Age at Illness Onset in Schizophrenia Associated With Increased Genetic Susceptibility? Analysis of Data From the Nationwide Danish Twin Register.

Authors:  Rikke Hilker; Dorte Helenius; Birgitte Fagerlund; Axel Skytthe; Kaare Christensen; Thomas M Werge; Merete Nordentoft; Birte Glenthøj
Journal:  EBioMedicine       Date:  2017-04-06       Impact factor: 8.143

3.  Sex difference in association of symptoms and white matter deficits in first-episode and drug-naive schizophrenia.

Authors:  Xiao-E Lang; Daomin Zhu; Guangya Zhang; Xiangdong Du; Qiufang Jia; Guangzhong Yin; Dachun Chen; Meihong Xiu; Bo Cao; Li Wang; Xiaosi Li; Jair C Soares; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2018-12-18       Impact factor: 6.222

4.  The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective.

Authors:  Stephan Hjorth
Journal:  Front Psychiatry       Date:  2021-11-24       Impact factor: 4.157

5.  The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study.

Authors:  Laura Ferraro; Caterina La Cascia; Daniele La Barbera; Teresa Sanchez-Gutierrez; Giada Tripoli; Fabio Seminerio; Crocettarachele Sartorio; Giovanna Marrazzo; Lucia Sideli; Celso Arango; Manuel Arrojo; Miguel Bernardo; Julio Bobes; Cristina Marta Del-Ben; Charlotte Gayer-Anderson; Hannah E Jongsma; James B Kirkbride; Antonio Lasalvia; Sarah Tosato; Pierre-Michel Llorca; Paulo Rossi Menezes; Bart P Rutten; Jose Luis Santos; Julio Sanjuán; Jean-Paul Selten; Andrei Szöke; Ilaria Tarricone; Roberto Muratori; Andrea Tortelli; Eva Velthorst; Victoria Rodriguez; Andrea Quattrone; Peter B Jones; Jim Van Os; Evangelos Vassos; Craig Morgan; Lieuwe de Haan; Ulrich Reininghaus; Alastair G Cardno; Marta Di Forti; Robin M Murray; Diego Quattrone
Journal:  Schizophr Res       Date:  2021-08-14       Impact factor: 4.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.